首页> 外文期刊>Human Pathology: Case Reports >An unusual presentation of blast phase in JAK 2 mutated polycythemia vera
【24h】

An unusual presentation of blast phase in JAK 2 mutated polycythemia vera

机译:JAK 2突变多胆血症VERA中BLAST阶段的异常呈现

获取原文
获取外文期刊封面目录资料

摘要

Leukemic transformation in Polycythemia Vera (PV) is described as a rare and late event, less common than primary myelofibrosis (PMF). Blast phase in PV (PV-BP) develops at a median time of 12.8?years from diagnosis which implies a long-lasting exposure to myelosuppressive agents. Acute megakaryocytic leukemia (FAB M7) and acute myelomonocytic leukemia (FAB M4) are the common morphologic types described in blast phase of myeloproliferative neoplasms (MPN). Here we report a case of a 61?year old male who progressed to blast phase within three years of diagnosis of PV and was on cytoreduction with hydroxyurea. The leukemic transformation occurred in the form of pure erythroid leukemia (FAB M6) and was not preceded by a phase of documented post PV myelofibrosis (post PV- MF). The unusual features in this case include the short period from initial diagnosis to leukemic transformation and the uncommon morphologic subtype.
机译:PolyCydemia Vera(PV)的白血病转化被描述为稀有和晚期的事件,不如原发性髓颤(PMF)不太常见。 PV(PV-BP)的BLAST期在诊断中在12.8岁的中位时间发育,这意味着对髓抑制剂的长期暴露。 急性巨核细胞白血病(Fab M7)和急性骨髓细胞白血病(Fab M4)是Myeloproiferative肿瘤(MPN)的喷砂阶段中描述的常见形态学类型。 在这里,我们举报了一个61?岁月的案例,在诊断到PV的诊断中,在诊断到PV并与羟基脲进行细胞渗透。 白血病转化发生在纯红细胞白血病(Fab M6)的形式中,并且未在PV Myelofibrosis(PV-MF后)的阶段。 这种情况下的不寻常特征包括从初始诊断到白血病转化和罕见形态亚型的短期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号